Thomas Β Cooper,

Q: What Schools Are Affiliated With Thomas Β Cooper,

Thomas Β Cooper, is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, Columbia University

Thomas Β Cooper,'s AcademicInfluence.com Rankings

Thomas Β Cooper,

Biology

#9086

World Rank

#12245

Historical Rank

Neuroscience

#1305

World Rank

#1350

Historical Rank

biology Degrees

Download Badge

Biology

Thomas Β Cooper,'s Degrees

Doctorate Psychiatry Stanford University

Why Is Thomas Β Cooper, Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas Β Cooper,'s Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. (1989) (1116)
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. (2000) (1039)
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. (2001) (635)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction (2005) (563)
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. (2002) (525)
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. (2003) (483)
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. (1998) (469)
Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. (1988) (461)
Circadian time of morning light administration and therapeutic response in winter depression. (2001) (347)
Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. (1998) (331)
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. (2003) (321)
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. (1996) (319)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. (2005) (307)
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. (2006) (301)
Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. (1992) (263)
Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. (1989) (261)
Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. (2003) (251)
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. (2002) (237)
β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients (1977) (230)
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. (2009) (224)
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. (1998) (215)
Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims (2004) (204)
Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder (2002) (192)
Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. (1997) (191)
Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. (1996) (191)
Relationship between age and tricyclic antidepressant plasma levels. (1977) (189)
Human brain fluoxetine concentrations. (1993) (187)
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers (1993) (177)
Overt Aggression and Psychotic Symptoms in Patients With Schizophrenia Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol (2004) (176)
Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association (2002) (174)
Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. (1990) (155)
Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. (1998) (149)
Low testosterone levels in elderly men with dysthymic disorder. (2002) (140)
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. (2000) (139)
A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. (1989) (139)
Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane (1998) (136)
The 24-hour serum lithium level as a prognosticator of dosage requirements. (1973) (133)
Evaluation of lithium therapy in chronic and periodic alcoholism (1974) (133)
Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain (1992) (131)
Plasma Level Monitoring of Antipsychotic Drugs (1978) (131)
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. (2004) (130)
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. (1987) (127)
Lower Cortisol Levels in Depressed Patients with Comorbid Post-Traumatic Stress Disorder (2003) (127)
Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder. (1992) (125)
Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing. (1997) (124)
Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims (2005) (120)
Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography (2006) (118)
Imipramine in adolescent major depression: plasma level and clinical response (1986) (116)
Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness (1997) (116)
Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. (2003) (114)
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial (2017) (112)
Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly (1986) (109)
A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder (2015) (109)
The use of imipramine in depressed patients with congestive heart failure. (1983) (108)
Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents (1992) (106)
Dopamine receptor occupancy and plasma haloperidol levels. (1989) (106)
Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice (2006) (105)
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. (2010) (104)
Decreased serotonin function in bulimia nervosa. (1997) (102)
Pharmacokinetics of betamethasone in twin and singleton pregnancy (2002) (101)
Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. (1998) (101)
Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior (2016) (97)
Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. (1981) (95)
Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system (2006) (90)
Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial (1996) (89)
Low Cerebrospinal Fluid Transthyretin Levels in Depression: Correlations with Suicidal Ideation and Low Serotonin Function (2006) (89)
Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice (2010) (86)
Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. (1986) (85)
Formation of fatty acid ethyl esters during chronic ethanol treatment in mice. (1988) (81)
Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection. (1984) (80)
Testosterone levels in suicide attempters with bipolar disorder. (2012) (77)
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. (2005) (76)
Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats (2012) (76)
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. (2004) (76)
Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy (2013) (73)
Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. (1997) (73)
Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers (1997) (71)
Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. (1991) (71)
Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls (1991) (69)
Methylphenidate Response, Psychopathology and Tardive Dyskinesia as Predictors of Relapse in Schizophrenia (1994) (66)
Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. (1992) (65)
Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. (1999) (65)
Dexmedetomidine increases the cocaine seizure threshold in rats. (2002) (64)
Tricyclic antidepressant and metabolite levels in chronic renal failure (1985) (62)
DNA Methylation Perturbations in Genes Involved in Polyunsaturated Fatty Acid Biosynthesis Associated with Depression and Suicide Risk (2015) (62)
Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. (2013) (61)
Disappearance of memory deficits in outpatient depressives responding to imipramine. (1991) (60)
Weight Gain During a Double-Blind Multidosage Clozapine Study (2007) (59)
Future Suicide Attempt and Responses to Serotonergic Challenge (2010) (58)
Hormone responses to fenfluramine and placebo challenge in endogenous depression (1992) (57)
Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. (1997) (57)
How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate. (1988) (56)
Further evidence of low baseline cortisol levels in suicide attempters. (2016) (55)
Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. (1995) (53)
The tyramine challenge test as a marker for melancholia. (1984) (53)
Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2. (1998) (53)
Drug treatment of depression in frail elderly nursing home residents. (2000) (53)
Serum Antimuscarinic Activity During Clozapine Treatment (2003) (53)
Effects of chronic antidepressant treatment on serotonin receptor activity in mice. (1983) (53)
Plasma clozapine concentration coefficients of variation in a long-term study (2004) (53)
Gender-related differences in cocaine toxicity in the rat. (1993) (52)
GLC analysis of loxapine, amoxapine, and their metabolites in serum and urine. (1979) (52)
Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. (1983) (52)
Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder (2005) (52)
Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography. (1997) (51)
Prediction of individual dosage of nortriptyline. (1978) (50)
Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. (2005) (50)
Does clozapine decrease smoking? (2005) (48)
Factors affecting the delay of antidepressant effect in responders to Nortriptyline and Phenelzine (1989) (48)
ANXIETY IN MAJOR DEPRESSION AND CEREBROSPINAL FLUID FREE GAMMA‐AMINOBUTYRIC ACID (2014) (48)
Early findings from a pharmacokinetically designed double-blind and placebo-controlled study of lithium for adolescents comorbid with bipolar and substance dependency disorders (1992) (48)
Effect of antiparkinsonian medication on plasma levels of chlorpromazine. (1980) (48)
Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. (1989) (48)
Response of Depressive Symptoms to Nortriptyline, Phenelzine and Placebo (1987) (47)
Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: Response to acute serotonin deficiency (2005) (46)
Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. (1997) (46)
WILL AMITRIPTYLINE PREVENT THE "CHEESE" REACTION OF MONOAMINE-OXIDASE INHIBITORS? (1982) (43)
Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. (1995) (43)
Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients. (2000) (42)
Dr. Douyon and Associates Reply (1989) (42)
Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. (2016) (41)
Evaluation of a slow-release lithium carbonate formulation. (1978) (41)
Association of testosterone levels and future suicide attempts in females with bipolar disorder. (2014) (41)
Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects (1996) (41)
Plasma tryptophan during weight restoration in patients with anorexia nervosa (2005) (40)
Acute d-amphetamine challenge in schizophrenia: Effects on cerebral glucose utilization and clinical symptomatology (1994) (40)
Prenatal exposure to imipramine alters early behavioral development and beta adrenergic receptors in rats. (1981) (40)
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. (1996) (39)
Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status. (1976) (38)
High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. (1990) (38)
Uncoupling of the Noradrenergic-Hypothalamic-Pituitary-Adrenal Axis in Panic Disorder Patients (1995) (38)
Serotonin Function Following Remission from Bulimia Nervosa (2000) (38)
A Pulmonary Formulation of l-Dopa Enhances Its Effectiveness in a Rat Model of Parkinson's Disease (2004) (38)
Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans. (1985) (37)
Amphetamine and negative symptoms of schizophrenia (2005) (37)
Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. (1988) (36)
Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls (2003) (36)
Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012) (36)
Preliminary data on the relationship between nortriptyline plasma level and response in depressed children. (1986) (36)
Fenfluramine challenge test as a predictor of outcome in major depression. (1993) (35)
ANTIPSYCHOTIC-INDUCED VACUOUS CHEWING MOVEMENTS AND EXTRAPYRAMIDAL SIDE-EFFECTS ARE HIGHLY HERITABLE IN MICE (2010) (35)
Clozapine: Plasma levels and prolactin response (2004) (34)
Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate. (1982) (34)
Determination of plasma ziprasidone using liquid chromatography with fluorescence detection. (2004) (34)
A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector. (1975) (34)
Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic-mediated function. (1984) (34)
Clinical predictors of response to antidepressants in elderly patients (1987) (33)
The comparative toxicity of cocaine and its metabolites in conscious rats. (1999) (33)
Dexamethasone suppression test and plasma dexamethasone levels in bulimia. (1987) (33)
Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder. (2014) (32)
Monoamine Oxidase Inhibitors as Antidepressants (1980) (32)
Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol‐preferring sP rats (2012) (32)
Effects of electroconvulsive therapy on plasma vasopressin and oxytocin (1998) (32)
Haloperidol Half-life After Chronic Dosing (2004) (32)
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine (2020) (31)
A sensitive method for the determination of amitriptyline and nortriptyline in human plasma. (1976) (31)
Fluphenazine plasma levels, dosage, efficacy, and side effects. (1995) (31)
Age effects on cortisol levels in depressed patients with and without comorbid post-traumatic stress disorder, and healthy volunteers. (2004) (30)
Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD (1993) (30)
High-dose treatment with haloperidol: the effect of dose reduction. (2000) (29)
A cannabinoid analogue of Delta9-tetrahydrocannabinol disrupts neural development in chick. (2008) (29)
Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects (1998) (29)
Dose and plasma levels of nortriptyline and chlorpromazine in delusionally depressed adolescents and of nortriptyline in nondelusionally depressed adolescents. (1985) (29)
Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression (2020) (29)
Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts (1998) (27)
Cortisol levels, immune status, and mood in homosexual men with and without HIV infection. (1993) (27)
Determination of mianserin and metabolites in plasma by liquid chromatography with electrochemical detection. (1982) (27)
Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study. (2012) (27)
CORRELATION OF TYPE A BEHAVIOUR WITH ADRENERGIC RECEPTOR DENSITY: IMPLICATIONS FOR CORONARY ARTERY DISEASE PATHOGENESIS (1987) (27)
Simultaneous determination of amitriptyline, nortriptyline and their respective isomeric 10-hydroxy metabolites in plasma by liquid chromatography. (1982) (27)
Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers. (2013) (26)
Steady state pharmacokinetics of nortriptyline in the frail elderly. (1989) (26)
Determination of trimipramine and metabolites in plasma by liquid chromatography with electrochemical detection. (1984) (26)
5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response tod-fenfluramine challenge in physically healthy human subjects (1996) (26)
Higher cortisol levels in spring and fall in patients with major depression (2005) (26)
Lithium kinetics in man: effect of variation in dosage pattern (1973) (25)
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics (1993) (24)
Hypothalamic - Pituitary - Adrenocortical Function in Geriatric Depression: Diagnostic and Treatment implications (1984) (24)
Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. (1991) (24)
Fluphenazine blood levels and clinical response. (1982) (23)
The iodine requirement and influence of iodine intake on iodine metabolism and thyroid function in the adult beagle. (1975) (23)
Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine (1986) (23)
Effects of haloperidol and reduced haloperidol on binding to σ sites (1994) (23)
Elevated plasma tricyclic levels with therapeutic doses of imipramine. (1984) (23)
Child and Adolescent Nortriptyline Single Dose Pharmacokinetic Parameters: Final Report (1987) (22)
Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients. (1985) (22)
Beta-endorphin--induced changes in schizophrenic and depressed patients. (1977) (22)
The usefulness of DST in predicting response to antidepressants: a placebo-controlled study. (1986) (22)
Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine. (1982) (22)
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. (1990) (21)
Ketamine metabolite pilot study in a suicidal depression trial. (2019) (21)
A controlled sevn year study of endocrine and other indices in drug treated chronic schizophrenics. (1968) (21)
Plasma Levels of Catecholamines and Dihydroxyphenylglycol during Antidepressant Drug Treatment (1983) (21)
Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children. (1985) (21)
Relationship of platelet MAO activity to characteristics of major depressive illness (1986) (20)
Pregnancy alters the hemodynamic responses to cocaine in the rat. (1992) (20)
Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders Correlation with increased serotonergic responsivity (1994) (20)
Clozapine plasma level monitoring: Current status (1996) (20)
Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds. (1992) (20)
Effects of fenfluramine on plasma HVA in OCD (1992) (20)
A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients. (1987) (19)
Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. (1989) (19)
Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder (1998) (18)
Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study. (2017) (18)
The 24-hour lithium level as a prognosticator of dosage requirements: a 2-year follow-up study. (1976) (18)
Identification of drug-related cognitive impairment in older individuals. Challenge studies with diphenhydramine. (1997) (18)
Placental transfer of (3H)-GM1 and its distribution to maternal and fetal tissues of the rat. (1993) (18)
The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration (2005) (18)
Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder. (1996) (17)
The lithium test dose prediction method in aggressive children. (1995) (17)
Combined catecholamine and indoleamine depletion following response to ECT (2010) (17)
The apolipoprotein E ɛ4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge (2008) (17)
Relative safety of single versus divided dose imipramine in adolescent major depression. (1987) (17)
Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo. (1984) (17)
Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report. (1990) (17)
Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression. (2019) (17)
Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression (1988) (16)
Clinical and plasma level characteristics of intramuscular and oral loxapine (1978) (16)
The effect of imipramine treatment on brain serotonin receptors and β-adrenoceptors and on pineal β-adrenergic function in adult and aged rats (1986) (16)
Plasma tricyclic drug levels in amitriptyline-treated depressed patients (1979) (16)
Direct radioimmunoassay procedure for plasma dexamethasone with a sensitivity at the picogram level. (1989) (16)
Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias (1987) (16)
Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder (2005) (16)
Prospective study of scheduled withdrawal from nortriptyline in children and adolescents. (1987) (16)
Naloxone, tardive dyskinesia, and endogenous beta-endorphin (1982) (16)
Conversion of lipotropic peptides by purified cathepsin D of human pituitary: Release of γ-endorphin by cleavage of the Leu77-PHE78 bond (1978) (16)
Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding (2019) (16)
The treatment of affective disorders in the elderly. (1983) (15)
Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. (1991) (15)
Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels. (1975) (14)
Concomitant imipramine and methylphenidate administration: a case report. (1973) (14)
Pharmacokinetics of desipramine in Asian and Caucasian volunteers. (1989) (14)
Modification of ligand binding to membranes by a soluble acceptor Alpha-1-acid glycoprotein attenuates 3H-Imipramine binding to cerebral membranes (1986) (14)
2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults. (1991) (14)
Relationships Between Inflammatory Markers and Suicide Risk Status in Major Depression (2020) (14)
Prediction of response to nortriptyline and phenelzine by platelet MAO activity. (1987) (14)
Serotonin in violent patients with schizophrenia (1995) (14)
The relationship between blood levels of different forms of butaperazine and clinical response. (1973) (14)
The Effect of Mifepristone (RU 486) on Plasma Cortisol in Alzheimer’s Disease (2006) (14)
Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine (1992) (13)
The Number of Previous Depressive Episodes Is Positively Associated with Cortisol Response to Fenfluramine Administration (2004) (13)
Down regulation of β-receptors by bupropion and its major metabolite in mouse brain (1986) (13)
Neuroleptic plasma level may predict response in patients who meet a criterion for improvement. (1988) (13)
Inhibition of 3H-imipramine binding by plasma from depressed and normal subjects (1986) (13)
Prenatal ganglioside GM1 treatment protects ethanol‐induced sleep time in rats exposed to ethanol in utero during gestation days 7 and 8 (1991) (13)
Lithium and haloperidol (1986) (13)
Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode. (2009) (13)
A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine. (1988) (13)
Tyramine Sulfate excretion may be a better predictor of antidepressant response than Monoamine Oxidase activity (1988) (12)
Beta-endorphine-induced changes in schizophrenic and depressed patients N.S. Kline, C.H. Li, H.E. Lehmann, A. Lajtha, E. Laski and T. Cooper, Arch. gen. Psychiat., 34 (1977) 1111–1113 (1979) (12)
Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study. (1992) (12)
Serum prolactin levels in homosexual and bisexual men with HIV infection. (1992) (12)
Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. (1989) (12)
Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults (2006) (12)
Determination of phenelzine in human plasma with gas chromatography-mass spectrometry using an isotope labeled internal standard. (1980) (12)
Plasma dexamethasone and cortisol levels in depressed outpatients. (1989) (12)
Multidose Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia (2006) (12)
Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions. (1987) (11)
Pretreatment plasma HVA and haloperidol response in acute mania. (2000) (11)
Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients. (1990) (11)
Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence (2007) (11)
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO (2019) (11)
Thyroid indices in chronic schizophrenia. 3. (1966) (10)
Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol. (2003) (10)
Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients. (1982) (10)
Postmortem blood and tissue levels of loxapine and its metabolites. (1981) (10)
Preliminary report of a longitudinal study of the effects of lithium on iodine metabolism. (1969) (10)
Concurrent lithium administration results in higher haloperidol levels in brain and plasma of guinea pigs (1987) (10)
Dose-related differences in the distribution of cocaine in the maternal-fetoplacental compartments in rats. (2000) (10)
The nephrotoxicity of Isotropis forrestii in sheep. (1986) (9)
The recency ratio is associated with reduced CSF glutamate in late-life depression (2017) (9)
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats. (2020) (9)
Saliva and plasma desipramine levels in Asian and Caucasian volunteers. (1991) (9)
Measurement of lithium concentrations in human tears. (1982) (8)
Nortriptyline Pharmacokinetic Parameters in Depressed Children and Adolescents: Preliminary Data (1984) (8)
The effect of three butyrophenones on serum cholesterol levels. (1966) (8)
Placebo washout in trials of antipsychotic drugs. (1996) (8)
Tyramine Conjugation Deficit in Type Headache, and Depression Migraine, Tension- (1995) (8)
The disposition of cocaethylene in rat maternal, placental, and fetal compartments. (1999) (8)
Determination of 3,4-dihydroxyphenyl glycol in plasma by gas chromatography-mass spectrometry and high-performance liquid chromatography methods. (1996) (8)
Bioequivalency of generic and brand‐named chlorpromazine (1974) (8)
Monitoring Lithium Dose Levels: Estimation of Lithium in Blood and Other Body Fluids (1981) (8)
Lithium accumulation in the neurointermediate lobe of rat pituitary exceeds that in other endocrine glands (1993) (8)
Pharmacokinetics of desipramine in Caucasian and Asian volunteers. (1986) (8)
Prediction of Individual Dosage of Nortriptyline in Depressed Elderly Outpatients (1987) (7)
Pregnancy decreases the threshold for cocaine-induced convulsions in the rat. (1993) (7)
Role of gender in the toxicity of norcocaine. (1999) (7)
Protection of patients on MAOI's against hypertensive crises. (1981) (7)
Prevention of lithium nephrotoxicity in a novel one-hour model in rats (1998) (7)
Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry. (2002) (7)
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function (2005) (7)
Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents: preliminary data. (1985) (7)
Sensitive and simple gas chromatographic-mass spectrometric determination for amphetamine in microdialysate and ultrafiltrate samples. (2004) (6)
Pregnancy enhances cocaine-induced stimulation of uterine contractions in the chronically instrumented rat. (1996) (6)
The disposition of benzoylecgonine in maternal and fetal rats. (2001) (6)
Further studies on the effect of butyrophenones on cholesterol synthesis in humans. (1967) (6)
Omega-3 Polyunsaturated Fatty Acid Status in Major Depression with Comorbid Anxiety Disorders (2014) (6)
Neuroendocrine sensitivity in obsessive-compulsive disorder (1989) (6)
Neurohormonal and behavioral response to methylphenidate in cocaine abstinence (1996) (6)
Monitoring of clozapine blood levels in the real world. (1996) (6)
Serum dopamine-beta-hydroxylase activity in depression and anxiety. (1984) (6)
An Improved Method for the Determination of Reserpine in Plasma Using Liquid Chromatography with Fluorescence Detection (1983) (6)
Iodoamino acid distribution in the serum of schizophrenic patients receiving perphenazine. (1963) (6)
5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. (1996) (5)
Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors ofCebus apella monkeys (2005) (5)
Neuroleptic drug monitoring and radioreceptor assays. (1985) (5)
Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data. (1985) (5)
Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls (2008) (5)
Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment (1996) (5)
Long-term intravenous perinatal cocaine exposure on the mortality of rat offspring. (2000) (5)
A879 THE MATERNAL TO FETAL TRANSFER OF BENZOYLECGONINE (1997) (5)
elta-9-Tetrahydrocannabinol Effects in chizophrenia : Implications for Cognition , sychosis , and Addiction eepak (2005) (5)
Lithium and thyroid function. (1969) (5)
Different pattern of association of beta-endorphin and cortisol responses to dextroamphetamine in postmenopausal women and young men (1985) (5)
Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure (2004) (5)
Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. (1988) (5)
Monitoring lithium dose levels: estimation of lithium in blood and other body fluids. (1981) (5)
Phenelzine measurement in human plasma: a sensitive GLC-ECD procedure. (1978) (5)
Effects of imipramine and phenelzine on plasma PEA levels (1988) (5)
Magnesium and bupivacaine-induced convulsions in awake pregnant rats. (2005) (4)
Lithium, controversies and unresolved issues : proceedings of the International Lithium Conference, New York, June 5-9, 1978 (1979) (4)
Haloperidol Blood Levels in Acute Mania With Psychosis (2001) (4)
Lack of weight gain under desipramine (1987) (4)
Effects of loxapine on the sleep of chronic schizophrenics (1979) (4)
Effects of haloperidol and reduced haloperidol on binding to sigma sites. (1994) (4)
Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited. (1992) (4)
Amitriptyline protects patients on MAOIs from tyramine reactions. (1982) (4)
Plasma/blood level monitoring techniques in psychiatry. (1975) (4)
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder. (2018) (4)
Plasma drug level and clinical response. (1992) (3)
Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion (2009) (3)
The efficacy of melatonin in the treatment of jet lag (1998) (3)
The drug-free period: A methodological issue (1990) (3)
GLC/MS assay for loxapine in human biofluids and tissues with deuterium labeled analog as an internal standard. (1982) (3)
Lithium distribution in experimental inflammation of brain and spinal cord (1996) (3)
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. (1988) (3)
TWO-YEAR FOLLOW-UP STUDY OF PROTEIN-BOUND IODINE ELEVATION IN PATIENTS RECEIVING PERPHENAZINE. (1965) (3)
The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats. (1986) (3)
Will amitriptyline prevent the ???cheese??? reaction of monoamine oxidase inhibitors? (1983) (3)
Determination of amoxapine and metabolites in plasma by liquid chromatography with electrochemical detection. (1985) (2)
Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium. (1985) (2)
VACUUM MANIFOLD FOR USE IN ERYTHROCYTE UPTAKE OF T3 TECHNIC. (1965) (2)
Hydroxocobalamin and SodIum Thiosulfate Interfere Negatively wIth Measurement of Creatine Kinase ActIvIty (2004) (2)
Gas—Liquid Chromatography of Antidepressant, Antipsychotic, and Benzodiazepine Drugs in Plasma and Tissues (1988) (2)
5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response tod-fenfluramine challenge in healthy human subjects (1996) (2)
Post‐dexamethasone cortisol levels and computerized tomographic findings in manic patients (1993) (2)
Sensitiveand SelectiveLiquid-Chromatographic Assayof Fluoxetineand Norfluoxetine in PlasmawithFluorescence Detectionafter PrecolumnDerivatization (1992) (2)
Plasma homovanillic acid in psychotic depression (1993) (2)
Influence of body size on lithium levels in rats (1997) (2)
The implications of left ventricular performance for tricyclic antidepressant drug treatment (1983) (2)
2‐Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response? (1996) (2)
Influence of Strain, Sex and Age on Nephrotoxicity of Lithium in a One-Hour Model in Rats (2001) (2)
10-Hydroxynortriptyline and treatment effects in elderly depressed patients. (1989) (2)
Tricyclic Antidepressant Drug and Metabolite Levels in Chronic Renal Failure (1986) (2)
Brain regional [3H]flunitrazepam binding in rats chronically treated with bupropion or B.W.306U (1986) (1)
MUSCARINIC SUPERSENSITIVITY IN ALZHEIMER'S DISEASE–POS.S I BLE DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS (1988) (1)
Second International Symposium on the Economic and Social Costs of Substance Abuse (1997) (1)
Alcohol reduces GM1 ganglioside content in the serum of inbred mouse strains. (2004) (1)
Lithium dosing guide. (1982) (1)
Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography. (1988) (1)
Contribution to the mode of action of lithium on iodine metabolism. (1970) (1)
DISPOSITION OF COCAETHYLENE IN THE MATERNAL-PLACENTAL AND FETAL UNIT IN THE AWAKE RAT (1998) (1)
Maternal Cerebrospinal Fluid Glutamate in Response to Variable Foraging Demand: Relationship to Cerebrospinal Fluid Serotonin Metabolites in Grown Offspring (2018) (1)
Plasma-serum differences in the assessment of tricyclic antidepressant blood levels. (1987) (1)
THYROXINE SERUM PROTEIN COMPLEXES IN SCHIZOPHRENIA. (1965) (1)
Analytical Aspects of the Pharmacokinetics of Psychotropic Drugs (1982) (1)
Effects of lithium on seizure susceptibility in alcoholized and non-alcoholized rats. (1977) (1)
Pregnancy Enhances Acute Intoxication By Cocaine In The Rat (1989) (1)
Usefulness of single plasma desipramine levels. (1983) (1)
Plasma Levels of Antidepressants and Therapeutic Effects1 (1981) (1)
Baseline Plasma GABA: Its Relationship to the Adverse Effects of Acute Lorazepam Administration on Cognition in the Elderly (2004) (1)
REDUCED SEROTONIN RESPONSIVITY IN DEPRESSION. AUTHORS' REPLY (1997) (0)
placeboof depressive symptoms to nortriptyline, phenelzine and (2011) (0)
Dr. Bilder and Colleagues Reply (2002) (0)
Contents Vol. 89, 2001 (2001) (0)
Comment on “does oxytocin release correlate with ECT's efficacy?” (1994) (0)
427. Reduced heart rate response to nortriptyline in females with unipolar depression (1996) (0)
THYROID INDICES IN CHRONIC SCHIZOPHRENIA: III (1966) (0)
Decreased Tyramine Conjugation in Melancholia: A Trait Marker (1988) (0)
Effects of fenfluramine on plasma homovanillic acid in healthy subjects (2005) (0)
The effect of nortriptyline on verbal recall (1995) (0)
Disposition of Cocaine in Pre-and-Postnatally Cocaine Exposed Rat Offspring: [2002][A-1057] (2002) (0)
S65. MATERNAL CORTISOL DURING PREGNANCY, SCHIZOPHRENIA, AND FETAL GROWTH (2019) (0)
PREGNANCY ALTERS THE PHARMACODYNAMICS OF COCAINE IN RATS (1991) (0)
SECTION V: THYROID FUNCTION (1968) (0)
Inconsistency in Developing Neurobehavioral Toxicity of Cocaine in the Newborn Rat: I. Kinetic Considerations (1994) (0)
Corrigendum to"Ketamine metabolite pilot study in a suicidal depression trial" [J Psychiatr Res 117 (2019) 129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9]. (2019) (0)
Pharmacodynamics of Cocaine and Uterine Activity in the Rat (1994) (0)
Antidepressantsin the Treatment of Post-PsychoticDepressionin Schizophrenia:Drug Interactionsand other Considerations (2004) (0)
Factors Affecting the Delay of Antidepressant Responders to Nortriptyline and Phenelzine (1989) (0)
The effect of phenothiazines on cerebrospinal fluid. (1966) (0)
Reply from Dr. Stern and associates (1992) (0)
The Effect Of MgSO4 On Bupivacaine-Induced Convulsions In Awake Rats. A16 (2000) (0)
PLACENTAL TRANSFER AND DISPOSTION OF COCAINE IN THE PREGNANT SHEEP (1992) (0)
Short communication Does clozapine decrease smoking (2005) (0)
Ovarian hormones mediate the prophylactic efficacy of (R,S)-ketamine and (2R,6R)-hydroxynorketamine in female mice (2019) (0)
Studies on the mechanism of lithium action: preliminary report. (1975) (0)
Production of Metabolites of L-Deprenyl and pFluoro-L-Deprenyl in Rat Brain After Central Administration (1997) (0)
PS278. Association of testosterone levels and future suicide attempts in women with bipolar disorder: A prospective study (2016) (0)
therapy in patients with major depression Enhanced serotonergic responsivity following electroconvulsive (2011) (0)
Salivary lithiolith? (1983) (0)
Dr. Volavka and Colleagues Reply (2003) (0)
Post-dexamethasone cortisol levels and third ventricular enlargement in manic patients (1989) (0)
Longitudinal studies on depressed elderly (1989) (0)
Behavioral and Neuroendocrine Responses to Oral m-Chlorophenylpiperazine and Fenfluramine in Patients and Healthy Volunteers (2016) (0)
Serum concentrations of secondary amine tricyclic antidepressants may be lower than those measured from plasma. (1987) (0)
PLACENTAL TRANSFER AND DISTRIBUTION OF GANGLIOSIDE GM1 IN PREGNANT RATS AND THEIR FETUSES (1992) (0)
Comparative effectiveness of antipsychotic drugs. Authors' reply (2003) (0)
Lack of effect of M-CPP on noradrenergic and dopaminergic systems in women (1993) (0)
Acute HVA and prolactin response to fluphenazine challenge in patients with psychosis and/or stimulant abuse (1989) (0)
Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients (2004) (0)
SECTION VIII: DISCUSSION (1968) (0)
Species-Related Differences in Bupivacaine Metabolites during Pregnancy: [2002][A-1038] (2002) (0)
102-2 ECT and altered serotonergic responsivity (1997) (0)
Time course of subjective side effects on desipramine (1989) (0)
A929 AGE-RELATED COCAINE UPTAKE IN RATS (1990) (0)
Pertussis vaccine and pertussis toxin increase lithium levels in rats: Possible role of g-proteins (2000) (0)
Perphenazine and serum protein bound iodine. (1968) (0)
Reply (2007) (0)
Long-term Ingestion of Cocaine Decreases Its Toxic Threshold (1994) (0)
Randomized Controlled Trial Relapse Following Electroconvulsive Therapy : A Continuation Pharmacotherapy in the Prevention of Correction (2001) (0)
MATERNAL AND FETAL SUPPRESSION OF SERUM METHIONINE AFTER PROLONGED EXPOSURE TO NITROUS OXIDE (1988) (0)
Subject Index Vol. 89, 2001 (2001) (0)
A Study of the Pericycle in the Caprifoliaceae (1939) (0)
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranes (2004) (0)
Room I, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Neurotoxicity of Benzoylecgonine A-1058 (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas Β Cooper,?

Thomas Β Cooper, is affiliated with the following schools: